Hydrogenology
Source-linked study record

Hydrogen-rich medium alleviates high glucose-induced oxidative stress and parthanatos in rat Schwann cells in vitro

Li Q, Jiao Y, Yu Y, Wang G, Yu Y. · Molecular Medicine Reports. 2019;19(1):338–344.

PreclinicalOther formsPublished 2019Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Primary rat Schwann cells exposed for 48 hours to normal-glucose or high-glucose culture conditions as an in-vitro model relevant to diabetic peripheral neuropathy.

Intervention and dose

High-glucose cells were cultured for 48 hours in medium saturated with molecular H₂ at 0.6 mM. · For preparation, H₂ at 1 L/min was mixed with air at 1 L/min and dissolved in medium for four hours at 0.4 MPa; the stored medium was maintained at 0.6 mM H₂.

Duration

48-hour culture treatment; H₂-rich medium was freshly prepared weekly.

Reported result

Under high glucose, H₂-rich medium improved viability and reduced cytotoxicity, oxidative markers, 8-OHdG, PAR and AIF nuclear translocation. The experiment did not test neuropathy, nerve function or clinical outcomes in animals or people.

Main limitation

Small in-vitro replicate counts, one cell type, high-glucose model, multiple mechanistic endpoints and no in-vivo dose, exposure, safety or functional outcome. Chinese public and university grants funded the work; authors declared no competing interests and identified the commercial H₂-generator manufacturer.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Randomized four-condition primary rat Schwann-cell experiment

Research topic

Metabolic and lipid health

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Primary rat Schwann cells exposed for 48 hours to normal-glucose or high-glucose culture conditions as an in-vitro model relevant to diabetic peripheral neuropathy.

Sample

Outcome-specific laboratory replicates were n=5 per condition for viability/cytotoxicity and generally n=3 per condition for oxidative, DNA-damage and protein measures; no animal treatment experiment was performed.

Duration

48-hour culture treatment; H₂-rich medium was freshly prepared weekly.

Intervention

High-glucose cells were cultured for 48 hours in medium saturated with molecular H₂ at 0.6 mM.

Hydrogen form

H₂ dissolved in cell-culture medium — H₂ only, not Brown's gas and not inhalation.

Dose or H₂ specification

For preparation, H₂ at 1 L/min was mixed with air at 1 L/min and dissolved in medium for four hours at 0.4 MPa; the stored medium was maintained at 0.6 mM H₂.

Comparator

Normal-glucose medium, H₂-rich normal-glucose medium and high-glucose medium without H₂.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Cell viability, LDH cytotoxicity, hydroxyl-radical and peroxynitrite measures, 8-OHdG, PAR expression and AIF nuclear translocation.

Reported result

Under high glucose, H₂-rich medium improved viability and reduced cytotoxicity, oxidative markers, 8-OHdG, PAR and AIF nuclear translocation. The experiment did not test neuropathy, nerve function or clinical outcomes in animals or people.

Extraction completeness

The complete free PMC article and figures were checked for culture allocation, preparation flows and concentration, outcome-specific replicate counts, results, funding and conflicts.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Small in-vitro replicate counts, one cell type, high-glucose model, multiple mechanistic endpoints and no in-vivo dose, exposure, safety or functional outcome. Chinese public and university grants funded the work; authors declared no competing interests and identified the commercial H₂-generator manufacturer.

Applies directly to

Primary rat Schwann cells in culture; it does not establish prevention or treatment of diabetic peripheral neuropathy in people.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 30431142 · DOI: 10.3892/mmr.2018.9631

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.